148 related articles for article (PubMed ID: 35750011)
1. Hypouricemic effect of 2,4-dihydroxybenzoic acid methyl ester in hyperuricemic mice through inhibiting XOD and down-regulating URAT1.
Yong T; Liang D; Xiao C; Huang L; Chen S; Xie Y; Gao X; Wu Q; Hu H; Li X; Liu Y; Cai M
Biomed Pharmacother; 2022 Sep; 153():113303. PubMed ID: 35750011
[TBL] [Abstract][Full Text] [Related]
2. Caffeic acid phenethyl ester alleviated hypouricemia in hyperuricemic mice through inhibiting XOD and up-regulating OAT3.
Yong T; Liang D; Chen S; Xiao C; Gao X; Wu Q; Xie Y; Huang L; Hu H; Li X; Liu Y; Cai M
Phytomedicine; 2022 Aug; 103():154256. PubMed ID: 35714456
[TBL] [Abstract][Full Text] [Related]
3. Hypouricemic Effect of 2,5-Dihydroxyacetophenone, a Computational Screened Bioactive Compound from
Liang D; Yong T; Chen S; Xie Y; Chen D; Zhou X; Li D; Li M; Su L; Zuo D
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29735945
[TBL] [Abstract][Full Text] [Related]
4. Hypouricemic Effects of
Yong T; Chen S; Xie Y; Chen D; Su J; Shuai O; Jiao C; Zuo D
Front Pharmacol; 2017; 8():996. PubMed ID: 29379442
[No Abstract] [Full Text] [Related]
5. Hypouricemic Effects of Armillaria mellea on Hyperuricemic Mice Regulated through OAT1 and CNT2.
Yong T; Chen S; Xie Y; Chen D; Su J; Shuai O; Hu H; Zuo D; Liang D
Am J Chin Med; 2018; 46(3):585-599. PubMed ID: 29595077
[TBL] [Abstract][Full Text] [Related]
6. (E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1.
Hu Q; Zhou M; Zhu H; Lu G; Zheng D; Li H; Hao K
Biomed Pharmacother; 2017 Feb; 86():88-94. PubMed ID: 27951420
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evaluation of a novel skeleton compound isobavachin (4',7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity.
Zhao Z; Luo J; Liao H; Zheng F; Chen X; Luo J; Chen Y; Zhao K; Zhang S; Tian J; Wu T; Li Y; Li L; Yang Y; Lin C; Zhang Q; Tian Y; Pang J
Bioorg Chem; 2023 Apr; 133():106405. PubMed ID: 36753966
[TBL] [Abstract][Full Text] [Related]
8. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.
Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J
Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645
[TBL] [Abstract][Full Text] [Related]
9. Hypouricemic Effects of Extracts from
Han S; Wei R; Han D; Zhu J; Luo W; Ao W; Zhong G
Biomed Res Int; 2020; 2020():2968135. PubMed ID: 32083126
[No Abstract] [Full Text] [Related]
10. Antihyperuricemic effect of mangiferin aglycon derivative J99745 by inhibiting xanthine oxidase activity and urate transporter 1 expression in mice.
Qin Z; Wang S; Lin Y; Zhao Y; Yang S; Song J; Xie T; Tian J; Wu S; Du G
Acta Pharm Sin B; 2018 Mar; 8(2):306-315. PubMed ID: 29719791
[TBL] [Abstract][Full Text] [Related]
11. Anserine beneficial effects in hyperuricemic rats by inhibiting XOD, regulating uric acid transporter and repairing hepatorenal injury.
Chen M; Ji H; Song W; Zhang D; Su W; Liu S
Food Funct; 2022 Sep; 13(18):9434-9442. PubMed ID: 35972268
[TBL] [Abstract][Full Text] [Related]
12. The dual actions of Sanmiao wan as a hypouricemic agent: down-regulation of hepatic XOD and renal mURAT1 in hyperuricemic mice.
Wang X; Wang CP; Hu QH; Lv YZ; Zhang X; Ouyang Z; Kong LD
J Ethnopharmacol; 2010 Mar; 128(1):107-15. PubMed ID: 20051260
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents.
Ao GZ; Zhou MZ; Li YY; Li SN; Wang HN; Wan QW; Li HQ; Hu QH
Bioorg Med Chem; 2017 Jan; 25(1):166-174. PubMed ID: 28340987
[TBL] [Abstract][Full Text] [Related]
14. Siwu decoction attenuates oxonate-induced hyperuricemia and kidney inflammation in mice.
Wang R; Ma CH; Zhou F; Kong LD
Chin J Nat Med; 2016 Jul; 14(7):499-507. PubMed ID: 27507200
[TBL] [Abstract][Full Text] [Related]
15. Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice.
Chen G; Tan ML; Li KK; Leung PC; Ko CH
J Ethnopharmacol; 2015 Dec; 175():14-20. PubMed ID: 26344851
[TBL] [Abstract][Full Text] [Related]
16. Effects of ChondroT on potassium Oxonate-induced Hyperuricemic mice: downregulation of xanthine oxidase and urate transporter 1.
Oh DR; Kim JR; Choi CY; Choi CH; Na CS; Kang BY; Kim SJ; Kim YR
BMC Complement Altern Med; 2019 Jan; 19(1):10. PubMed ID: 30621705
[TBL] [Abstract][Full Text] [Related]
17. Pallidifloside D from Smilax riparia enhanced allopurinol effects in hyperuricemia mice.
Hou PY; Mi C; He Y; Zhang J; Wang SQ; Yu F; Anderson S; Zhang YW; Wu XH
Fitoterapia; 2015 Sep; 105():43-8. PubMed ID: 26051087
[TBL] [Abstract][Full Text] [Related]
18. Actions of
Yong T; Chen S; Liang D; Zuo D; Diao X; Deng C; Wu Y; Hu H; Xie Y; Chen D
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340390
[No Abstract] [Full Text] [Related]
19. Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemia.
Zheng F; Mai S; Cen X; Zhao P; Ye W; Ke J; Lin S; Hu H; Guo Z; Zhang S; Liao H; Wu T; Tian Y; Zhang Q; Pang J; Zhao Z
Bioorg Chem; 2024 Jun; 147():107381. PubMed ID: 38669781
[TBL] [Abstract][Full Text] [Related]
20. Hypouricemic actions of exopolysaccharide produced by Cordyceps militaris in potassium oxonate-induced hyperuricemic mice.
Ma L; Zhang S; Yuan Y; Gao J
Curr Microbiol; 2014 Dec; 69(6):852-7. PubMed ID: 25086583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
